M&As this week: Ionisos, China Regenerative Medicine International, M3

Ionisos has announced the acquisition of sterilisation solutions specialist Stermed.

Free Report

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.

By GlobalData

By downloading this case study, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition strengthens the cold sterilisation specialist’s position in the market and expands its geographic position in southern France.

Both companies are based in France.

Chinese biotechnology company China Regenerative Medicine International Ltd plans to acquire a 20% share in Denmark-based image analysis software developer RetinaLyze A/S.

"The acquisition strengthens the cold sterilisation specialist’s position in the market and expands its geographic position in southern France."

M3 Inc plans to acquire Cosmotec Co Ltd for CNY1.06bn ($9.03m).

Both the entities involved in the acquisition are based in Japan.

Free Report

Medical Device Industry Landscape In Asia-Pacific

By GlobalData

Free Report

Medical Device Industry Landscape In Asia-Pacific

Recommended Reports

Ulcerative Colitis - China Drug Forecast and Market Analysis to 2022

Rheumatoid Arthritis – China Drug Forecast and Market Analysis to 2023

Free Report

Medical Device Industry Landscape In Asia-Pacific

Ulcerative Colitis - China Drug Forecast and Market Analysis to 2022

Rheumatoid Arthritis – China Drug Forecast and Market Analysis to 2023